Q&A

Beyond CDMO To Trusted Partner: An Interview With Peter Khoury, President And CEO, Ology Bioservices

Final approved by Resilience_inset article image_300dpi_30Apr2021-sized

(Note: in April 2021, Ology Bioservices® (Ology Bio) was acquired by National Resilience, Inc. (Resilience). Peter Khoury is transitioning to a consulting role as Ology Bio continues its work and expands the business.)

Ology Bioservices® (Ology Bio) is a US-based biopharmaceutical Contract Development and Manufacturing Organization (CDMO) providing CGMP (and non-GMP) high quality services to our clients for the development and production of cell and gene therapies, viral vectors, oncolytic viruses and vaccines against infectious diseases and cancer. Peter Khoury, Former President and CEO of Ology Bio, gives insight into growing the company, the biotech CMO industry, and what’s next for Ology Bio.

VIEW THE Q&A!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Cell & Gene? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: